D2-40 is Not a Specific Marker for Cells of Mesothelial Origin in Serous Effusions

Advances in Malignant Mesothelioma

2005 • 1,068 citations

Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas

2002 • 600 citations

Up-Regulation of the Lymphatic Marker Podoplanin, a Mucin-Type Transmembrane Glycoprotein, in Human Squamous Cell Carcinomas and Germ Cell Tumors

2005 • 598 citations

Rosai and Ackerman???s Surgical Pathology, 9th ed.

2004 • 443 citations

Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma

2004 • 280 citations

Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours

1999 • 263 citations

D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma

2005 • 254 citations

Role of Immunohistochemistry in Distinguishing Epithelial Peritoneal Mesotheliomas From Peritoneal and Ovarian Serous Carcinomas

1998 • 210 citations

Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells.

1995 • 193 citations

The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study

2005 • 174 citations

The Role of Desmin and N-Cadherin in Effusion Cytology

2001 • 167 citations

D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma

2005 • 161 citations

The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study

2006 • 160 citations

Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum

2002 • 155 citations

HBME‐1, MOC‐31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma

2000 • 139 citations

Diagnostic problems in serous effusions

1998 • 136 citations

WT1 MUTATION IN MALIGNANT MESOTHELIOMA AND WT1 IMMUNOREACTIVITY IN RELATION TOp53 AND GROWTH FACTOR RECEPTOR EXPRESSION, CELL-TYPE TRANSITION, AND PROGNOSIS

1997 • 120 citations

Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies

1999 • 101 citations

Lymphatic vessel density and lymph node metastasis in prostate cancer

2005 • 89 citations

Detection of Lymphatic Invasion in Primary Melanoma With Monoclonal Antibody D2-40

2005 • 85 citations

Immunohistochemical diagnosis of epithelioid mesotheliomas: A critical review of old markers, new markers

2002 • 72 citations

Expression of candidate tumor markers in ovarian carcinoma and benign ovary: Evidence for a link between epithelial phenotype and neoplasia

2004 • 70 citations

Malignant Effusions

1995 • 67 citations

Production of a monoclonal antibody specific for seminomas and dysgerminomas.

1986 • 67 citations

Malignant effusions. A multimodal approach to cytologic diagnosis

1995 • 63 citations

A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testis

1988 • 60 citations

Immunohistochemical staining of germ cell tumors and intratubular malignant germ cells of the testis using antibody to placental alkaline phosphatase and a monoclonal anti-seminoma antibody.

1991 • 49 citations

Immunohistochemical Comparison of Primary Peritoneal and Primary Ovarian Serous Papillary Carcinoma

2001 • 41 citations

A novel maturation marker for human Sertoli cells

1989 • 34 citations

Use of anti‐seminoma monoclonal antibody to confirm the diagnosis of mediastinal seminoma

1988 • 7 citations